RxDoctor Payments Data

Karoline Neumann, APRN

Family · Orlando, FLNPI 1407936164

Payments from drug & device makers

$1,005in general payments, 2019–2025

Across 17 payments — averaging $59.14 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Coloplast$337
  • Medtronic$219
  • Mentor Worldwide LLC$148
  • Guard Medical Inc.$127
  • E.r. Squibb & Sons, L.L.C.$95
  • Incyte Corporation$54
  • plus $24 from 1 others

What the payments were for

  • Food & beverage$1,005100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

21
22
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

CompanyPaymentsTotal
Coloplast10$337
Medtronic2$219
Mentor Worldwide LLC1$148
Guard Medical Inc.1$127
E.r. Squibb & Sons, L.L.C.1$95
Incyte Corporation1$54
Dentsply IH AB1$24

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$1,005 in reported general payments places this provider in the 70th percentile of 14,618 family providers in Florida.

See all family providers in Florida

Medicare billing

Part B allowed, 2024
$37,985
Medicare patients
172
Services billed
365

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Colestipol Hcl30$1,978
LoperamideLoperamide Hcl12$137

Paid to pharmacies, not to this prescriber.

Other family in Orlando

See the full list for Florida

Where these figures come from

Is this you, or does something look wrong? →